Literature DB >> 28975616

Percutaneous Feeding Tubes in Individuals with Advanced Dementia: Are Physicians "Choosing Wisely"?

Marzena Gieniusz1, Liron Sinvani2, Andrzej Kozikowski2, Vidhi Patel2, Christian Nouryan2, Myia S Williams2, Nina Kohn3, Renee Pekmezaris2, Gisele Wolf-Klein1.   

Abstract

OBJECTIVES: To evaluate physician knowledge and perceptions about the American Board of Internal Medicine/American Geriatrics Society (ABIM/AGS) Choosing Wisely recommendations regarding percutaneous endoscopic gastrostomy (PEG) in individuals with advanced dementia.
DESIGN: Multicenter, mixed-mode, anonymous questionnaire.
SETTING: Three tertiary and four community hospitals in New York. PARTICIPANTS: Internal medicine physicians (N = 168). MEASUREMENTS: Physician knowledge and perceptions regarding PEG tubes in individuals with advanced dementia.
RESULTS: Ninety-nine percent of physicians reported having cared for someone with advanced dementia; 95% had been involved in the PEG decision-making process; 38% were unsure whether the ABIM/AGSChoosing Wisely recommendations advise for or against PEG tubes in advanced dementia. Physicians who agreed that there is enough evidence to recommend against PEG placement for individuals with advanced dementia were more likely to know the ABIM/AGSChoosing Wisely recommendations (71% vs 28%, P < .001). Fifty-two percent felt in control of the PEG placement decision, and 27% expressed concerns about potential litigation. The most common factor influencing physicians was patient or decision-maker request (70%); 63% stated that families request PEG placement even when physician would not recommend it. Only 4% of the physicians would choose to have a PEG tube if they had advanced dementia.
CONCLUSION: Despite the scientific evidence supporting the ABIM/AGSChoosing Wisely recommendations against the use of PEG tubes in individuals with advanced dementia, numerous incentives for placement complicate the decision for PEG placement. In today's healthcare environment, it is incumbent upon healthcare practitioners to be aware of the available evidence and to provide leadership to guide this complex decision-making process to promote true person-centered care.
© 2017, Copyright the Authors Journal compilation © 2017, The American Geriatrics Society.

Entities:  

Keywords:  ABIM/AGSChoosing Wisely recommendations; percutaneous endoscopic gastrostomy; physician knowledge and perceptions

Mesh:

Year:  2017        PMID: 28975616     DOI: 10.1111/jgs.15125

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  6 in total

1.  Improving All-Cause Inpatient Mortality After Percutaneous Endoscopic Gastrostomy.

Authors:  Daniel J Stein; Matthew B Moore; Gila Hoffman; Joseph D Feuerstein
Journal:  Dig Dis Sci       Date:  2020-06-19       Impact factor: 3.199

2.  Toward Understanding the Use of Gastrostomy in Critically Ill Adults.

Authors:  Aluko A Hope
Journal:  Ann Am Thorac Soc       Date:  2019-06

3.  Guilt as an Influencer in End-of-Life Care Decisions for Nursing Home Residents With Advanced Dementia.

Authors:  Ashley Roach; Anita H Rogers; Meghan Hendricksen; Ellen P McCarthy; Susan L Mitchell; Ruth Palan Lopez
Journal:  J Gerontol Nurs       Date:  2022-01-01       Impact factor: 1.254

Review 4.  Gastrostomy tubes: Fundamentals, periprocedural considerations, and best practices.

Authors:  Anand Rajan; Peerapol Wangrattanapranee; Jonathan Kessler; Trilokesh Dey Kidambi; James H Tabibian
Journal:  World J Gastrointest Surg       Date:  2022-04-27

Review 5.  Tube Feeding in Individuals with Advanced Dementia: A Review of Its Burdens and Perceived Benefits.

Authors:  Ezekiel Oluwasayo Ijaopo; Ruth Oluwasolape Ijaopo
Journal:  J Aging Res       Date:  2019-12-19

6.  Mapping and understanding the decision-making process for providing nutrition and hydration to people living with dementia: a systematic review.

Authors:  Kanthee Anantapong; Nathan Davies; Justin Chan; Daisy McInnerney; Elizabeth L Sampson
Journal:  BMC Geriatr       Date:  2020-12-02       Impact factor: 4.070

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.